Home » Topics » Regulatory

Regulatory
RSS

FDA approves Nolvadex for prevention of breast cancer

Oct. 30, 1998

Purepac's generic diltiazem capsules tentatively approved by FDA

Oct. 28, 1998

Roche granted additional exclusivity for Versed from FDA

Oct. 23, 1998

Phase III trial of Nutropin Depot successfully completed; NDA filing slated for 1999

Oct. 23, 1998

Tacalcitol lotion equivalent to ointment in animal study

Oct. 23, 1998

Fexofenadine in the treatment of chronic idiopathic urticaria

Oct. 22, 1998

Versed Syrup approved for pediatric sedation

Oct. 21, 1998

Yamanouchi applies for approval of oral bisphosphonate in Japan

Oct. 21, 1998

Yamanouchi introduces novel formulation of antiemetic drug

Oct. 20, 1998

Verapamil recommended for first-line treatment of cluster headache

Oct. 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...